- Home
- PDLB vs CRDF Comparison
PDLB vs CRDF Comparison
Compare PDLB & CRDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDLB
- CRDF
- Stock Information
- Founded
- PDLB 1960
- CRDF 1999
- Country
- PDLB United States
- CRDF United States
- Employees
- PDLB N/A
- CRDF N/A
- Industry
- PDLB
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PDLB
- CRDF Health Care
- Exchange
- PDLB Nasdaq
- CRDF Nasdaq
- Market Cap
- PDLB 251.3M
- CRDF 196.2M
- IPO Year
- PDLB 2017
- CRDF N/A
- Fundamental
- Price
- PDLB $13.59
- CRDF $2.63
- Analyst Decision
- PDLB
- CRDF Strong Buy
- Analyst Count
- PDLB 0
- CRDF 4
- Target Price
- PDLB N/A
- CRDF $12.00
- AVG Volume (30 Days)
- PDLB 41.6K
- CRDF 1.1M
- Earning Date
- PDLB 04-25-2025
- CRDF 05-20-2025
- Dividend Yield
- PDLB N/A
- CRDF N/A
- EPS Growth
- PDLB 148.96
- CRDF N/A
- EPS
- PDLB 0.60
- CRDF N/A
- Revenue
- PDLB $86,682,000.00
- CRDF $683,000.00
- Revenue This Year
- PDLB $10.97
- CRDF N/A
- Revenue Next Year
- PDLB $8.59
- CRDF N/A
- P/E Ratio
- PDLB $22.61
- CRDF N/A
- Revenue Growth
- PDLB 12.39
- CRDF 39.96
- 52 Week Low
- PDLB $8.42
- CRDF $2.01
- 52 Week High
- PDLB $13.97
- CRDF $5.64
- Technical
- Relative Strength Index (RSI)
- PDLB 73.44
- CRDF 41.22
- Support Level
- PDLB $13.19
- CRDF $2.42
- Resistance Level
- PDLB $13.58
- CRDF $2.87
- Average True Range (ATR)
- PDLB 0.35
- CRDF 0.18
- MACD
- PDLB 0.21
- CRDF 0.01
- Stochastic Oscillator
- PDLB 97.13
- CRDF 24.42
About PDLB Ponce Financial Group Inc.
Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.